NociMed, Inc.
USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Nocimed ranks #23,097 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.
- #23,097
- of 49,997 US assignees by volume
- 39th percentile
- by Innovation Score (31.8/100)
- 25.1
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23097 · US Corporation #23,097 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #23,097/49,997
- PHOTO-FINISH Ningbo Forward Plastic
- CPC-NARROW A61B · 5 areas
- INNOV-THIN 31.8/100
- CLAIMS-DENSE 25.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ningbo Forward Plastic Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nocimed’s 31.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nocimed
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- NociMed · this assignee 32
NociMed · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nocimed's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nocimed?
Each dot is one of Nocimed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nocimed’s own 25.1 claims/patent is ABOVE the 8.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nocimed's grants concentrate
NociMed, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Nocimed sits between Ningbo Forward Plastic Co., Ltd. and Nostrum Energy PTE. Ltd..
Who files at NociMed's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ningbo Forward Pl…
Ningbo Forward Plastic Co., Ltd.
12 patents
- Ningbo Yousun Imp…
Ningbo Yousun Imp. and Exp. Co., Ltd
12 patents
- Nippon Tanshi
Nippon Tanshi Co., Ltd.
12 patents
- Nocell
NoCell Technologies, LLC
12 patents
- Normedix
NorMedix, Inc.
12 patents
- Norell
Norell, Inc.
12 patents
- Northern Trust
Northern Trust Corporation
12 patents
- Nostrum Energy PTE
Nostrum Energy PTE. Ltd.
12 patents
- Nocimed ◀
NociMed, Inc.
12 patents
What this shows NociMed holds 12 patents at rank #23,099, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near NociMed
By rank, the assignees closest to #23,099 in granted patent volume.
- Ningbo Forward Plastic Co., Ltd. #23,095 · 12 patents
- Ningbo Yousun Imp. and Exp. Co., Ltd #23,096 · 12 patents
- Nippon Tanshi Co., Ltd. #23,097 · 12 patents
- NoCell Technologies, LLC #23,098 · 12 patents
- NorMedix, Inc. #23,100 · 12 patents
- Norell, Inc. #23,101 · 12 patents
- Northern Trust Corporation #23,102 · 12 patents
- Nostrum Energy PTE. Ltd. #23,103 · 12 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in NociMed's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Nocimed's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 8.3% |
| 2016 | 3 | 25.0% |
| 2017 | 2 | 16.7% |
| 2018 | 1 | 8.3% |
| 2019 | 3 | 25.0% |
| 2020 | 1 | 8.3% |
| 2021 | 1 | 8.3% |
Which technologies does NociMed, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
NociMed, Inc.'s patent record in context - here's where to go next.
- NociMed, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #23,097 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare NociMed, Inc. against Ningbo Forward Plastic Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.